Cosmo Pharmaceuticals N.V. (FRA:C43)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	816	1,089	879	1,015	1,065	1,136
Market Cap Growth	23.93%	23.93%	-13.36%	-4.76%	-6.21%	10.07%
Enterprise Value	681	961	838	974	1,028	1,067
Last Close Price	50.00	67.50	53.04	59.07	57.95	71.97
PE Ratio	6.12	8.18	-	58.91	49.16	-
PS Ratio	3.06	4.08	9.48	9.94	16.37	18.64
PB Ratio	1.62	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	2.61	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	5.17	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	5.02	6.71	38.72	30.54	84.48	87.48
EV/Sales Ratio	2.53	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	4.19	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	4.54	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	4.31	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.00	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.01	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.01	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.46	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.27	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.39	3.39	3.22	1.45	11.77	11.06
Current Ratio	4.19	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	29.31%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	15.87%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Capital (ROIC)	20.39%	20.39%	-0.22%	2.66%	1.11%	0.20%
Return on Capital Employed (ROCE)	24.90%	24.90%	-	5.00%	1.40%	0.30%
Earnings Yield	1633.28%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	1935.12%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	384.60%	3.04%	3.77%	1.78%	1.64%	-
Payout Ratio	2408.80%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-194.10%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	209.10%	1.10%	5.72%	4.61%	-15.17%	1.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.